# Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection

> **NCT04423393** · PHASE1 · COMPLETED · sponsor: **Vir Biotechnology, Inc.** · enrollment: 113 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **BIOLOGICAL:** VIR-3434
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04423393
- **Lead sponsor:** Vir Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-26
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-11-25
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04423393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04423393, "Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04423393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*